Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage Ib Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03091816
What this trial is testing

Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer

Who this might be right for
Stage IA Non-Small Cell Lung CarcinomaStage IB Non-Small Cell Lung CarcinomaStage IIA Non-Small Cell Lung Carcinoma+1 more
University of Southern California 15
Testing effectiveness (Phase 2)Looking for participantsNCT07122687
What this trial is testing

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd. 170
Early research (Phase 1)Ended earlyNCT03064854
What this trial is testing

PDR001 in Combination With Platinum-doublet Chemotherapy and Other Immunology Agents in PD-L1 Unselected, Metastatic NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Ended earlyNCT04210037
What this trial is testing

Study of APG-1252 Plus Paclitaxel in Patients With Relapsed/Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
Ascentage Pharma Group Inc. 28
Early research (Phase 1)Active Not RecruitingNCT03819465
What this trial is testing

Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC

Who this might be right for
Metastatic Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca 175
Early research (Phase 1)Study completedNCT02191891
What this trial is testing

Xentuzumab (BI 836845) Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 32
Large-scale testing (Phase 3)Study completedNCT00373425
What this trial is testing

Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors

Who this might be right for
Non-small Cell Lung Cancer
OSI Pharmaceuticals 1,252
Early research (Phase 1)Looking for participantsNCT07638891
What this trial is testing

HDM2020 in Patients With Advanced Sq-NSCLC

Who this might be right for
Squamous Non-small Cell Lung Cancer(NSCLC)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 150
Not applicableUnknownNCT01254591
What this trial is testing

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Who this might be right for
Breast CancerColorectal CancerEsophageal Cancer+2 more
University College London (UCL) Cancer Institute 500
Very early researchEnded earlyNCT01707823
What this trial is testing

Low-Dose Acetylsalicylic Acid in Treating Patients With Stage I-III Non-Small Cell Lung Cancer

Who this might be right for
Adenocarcinoma of the LungRecurrent Non-small Cell Lung CancerStage IA Non-small Cell Lung Cancer+5 more
Vanderbilt-Ingram Cancer Center 4
Early research (Phase 1)Looking for participantsNCT03819296
What this trial is testing

Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer

Who this might be right for
Clinical Stage 0 Cutaneous Melanoma AJCC v8Clinical Stage I Cutaneous Melanoma AJCC v8Clinical Stage IA Cutaneous Melanoma AJCC v8+41 more
M.D. Anderson Cancer Center 800
Early research (Phase 1)UnknownNCT05223595
What this trial is testing

Gentuximab in Combination With Almonertinib in EGFR Mutation-positive Metastatic NSCLC

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
Changchun GeneScience Pharmaceutical Co., Ltd. 42
Testing effectiveness (Phase 2)Looking for participantsNCT05910827
What this trial is testing

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

Who this might be right for
Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+4 more
Hummingbird Bioscience 398
Testing effectiveness (Phase 2)Looking for participantsNCT07264569
What this trial is testing

Evaluate the Safety, Tolerability, Biodistribution Characteristics and Preliminary Efficacy of BioTTT001

Who this might be right for
Meningeal Metastasis
Henan Cancer Hospital 42
Not applicableStudy completedNCT04183218
What this trial is testing

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Esophageal Adenocarcinoma AJCC v8+53 more
Mayo Clinic 24
Testing effectiveness (Phase 2)Looking for participantsNCT06996782
What this trial is testing

A Platform Study in Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced or Metastatic Non-small Cell Lung Cancer
AstraZeneca 152
Early research (Phase 1)Ended earlyNCT04287894
What this trial is testing

Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment

Who this might be right for
Stage III NSCLC
The Netherlands Cancer Institute 18
Not applicableUnknownNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)UnknownNCT03475953
What this trial is testing

A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors

Who this might be right for
Colorectal Cancer Not MSI-H or MMR-deficientGISTOesophageal or Gastric Carcinoma+12 more
Institut Bergonié 747
Not applicableStudy completedNCT03867916
What this trial is testing

Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients

Who this might be right for
CaregiverMalignant NeoplasmPhysician+24 more
University of California, San Francisco 106
Next Page